DPP4 and Hyperglycemia: Highly selective dipeptidyl peptidase IV (DPP IV) inhibitors control hyperglycaemia by stimulating insulin production via prevention of the degradation of two major incretins, glucagon-like peptide-1 (GLP-1) and glucose inhibitory peptide (GIP).